Evrofarma SA (ATH:EVROF)

Evrofarma Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	5.58	6.56	3.32	0.66	1.44	0.25
Cash & Short-Term Investments	5.58	6.56	3.32	0.66	1.44	0.25
Cash Growth	-25.81%	97.47%	405.94%	-54.28%	477.11%	-91.99%
Receivables	10.35	10.21	7.37	9.17	11.72	13.69
Inventory	8.93	7.07	7.11	6.52	5.56	3.07
Other Current Assets	0.04	-	-	-0	-	-
Total Current Assets	24.9	23.85	17.8	16.34	18.71	17.01
Property, Plant & Equipment	30.95	26.02	24.87	25.57	24.95	24.41
Long-Term Investments	0.01	0.01	0.01	0.01	0.06	0.04
Other Intangible Assets	0.4	0.35	0.13	0.05	0.06	0.1
Long-Term Accounts Receivable	0.19	0.33	0.03	0.33	0.03	0.03
Other Long-Term Assets	6.06	5.8	5.4	5.06	5.01	4.94
Total Assets	62.51	56.35	48.24	47.36	48.81	46.52

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	10.14	4.08	2.43	2.39	4.45	3.44
Accrued Expenses	-	0.57	0.53	0.5	0.45	0.87
Short-Term Debt	2.52	-	9.95	3.9	2.44	0.72
Current Portion of Long-Term Debt	-	1.99	1.64	3.08	2.71	2.5
Current Portion of Leases	0.06	0.06	0.07	0.04	0.04	0.03
Current Income Taxes Payable	1.31	0.73	0.49	0.4	0.11	-
Other Current Liabilities	0	3.26	3.17	2.73	2.48	2.64
Total Current Liabilities	14.02	10.7	18.26	13.04	12.67	10.2
Long-Term Debt	15.34	14.94	5.16	12.45	16.13	18.05
Long-Term Leases	0.04	0.07	0.14	0.07	0.06	0.01
Long-Term Unearned Revenue	8.61	8.78	5.73	4.43	4.69	4.42
Pension & Post-Retirement Benefits	0.09	0.09	0.08	0.07	0.05	0.05
Long-Term Deferred Tax Liabilities	1.17	1.11	1.04	1.08	1.18	1.18
Other Long-Term Liabilities	-0	-	-0	-	-0	-
Total Liabilities	39.27	35.69	30.41	31.13	34.79	33.92

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	5.74	5.74	5.74	5.74	12.03	12.03
Additional Paid-In Capital	-	-	-	-	0.94	0.94
Retained Earnings	12.94	10.84	8.46	7.42	-1.49	-0.38
Treasury Stock	-0.03	-0.01	-	-	-	-
Comprehensive Income & Other	4.59	4.08	3.62	3.06	2.55	0.02
Shareholders' Equity	23.24	20.66	17.83	16.23	14.03	12.61
Total Liabilities & Equity	62.51	56.35	48.24	47.36	48.81	46.52

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	17.96	17.06	16.95	19.53	21.38	21.31
Net Cash (Debt)	-12.38	-10.5	-13.63	-18.87	-19.94	-21.06
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-0.91	-0.77	-1.00	-1.38	-1.46	-1.54
Filing Date Shares Outstanding	13.67	13.67	13.67	13.67	13.67	13.67
Total Common Shares Outstanding	13.67	13.67	13.67	13.67	13.67	13.67
Working Capital	10.88	13.15	-0.46	3.3	6.04	6.81
Book Value Per Share	1.70	1.51	1.30	1.19	1.03	0.92
Tangible Book Value	22.84	20.31	17.69	16.18	13.97	12.51
Tangible Book Value Per Share	1.67	1.49	1.29	1.18	1.02	0.91

Data Source: S&P Global Market Intelligence Last updated: Apr 18, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Oct 2, 2026

Data Sources Report a data error